Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

1.6K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.6K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.6K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.6K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

1.7K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.7K
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Hormonal Regulation01:40

Hormonal Regulation

48.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
48.4K
Hormonal Regulation01:33

Hormonal Regulation

36.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spermatogonial Gene Networks Selectively Couple to Glutathione and Pentose Phosphate Metabolism but Not Cysteine Biosynthesis.

iScience·2021
Same author

Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation.

Contraception·2020
Same author

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.

American journal of obstetrics and gynecology·2020
Same author

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.

Obstetrics and gynecology·2020
Same author

Controlled Ovarian Stimulation Protocols Alter Endometrial Histomorphology and Gene Expression Profiles.

Reproductive sciences (Thousand Oaks, Calif.)·2020
Same author

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.

The New England journal of medicine·2020
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
Same journal

The prevalence of functional iron deficiency and its impact on mortality in patients receiving hemodialysis.

Postgraduate medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

12.0K

Hirsutism and virilization.

Paul B Marshbun, Bruce R Carr

    Postgraduate Medicine
    |December 9, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Hirsutism, or unwanted body hair in women, is usually benign but can signal tumors. Treatment ranges from lifestyle changes to surgery.

    More Related Videos

    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
    06:24

    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

    Published on: January 10, 2025

    1.6K
    Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
    07:37

    Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

    Published on: August 16, 2024

    2.2K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
    08:20

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

    Published on: October 2, 2018

    12.0K
    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
    06:24

    Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

    Published on: January 10, 2025

    1.6K
    Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
    07:37

    Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

    Published on: August 16, 2024

    2.2K

    Area of Science:

    • Endocrinology
    • Gynecology
    • Dermatology

    Background:

    • Unwanted body hair in women, known as hirsutism, is a common concern.
    • While often benign, hirsutism can indicate underlying medical conditions.

    Purpose of the Study:

    • To categorize the causes of hirsutism.
    • To review current treatment options for hirsutism.

    Main Methods:

    • Literature review of hirsutism causes and treatments.
    • Analysis of medical and cosmetic therapeutic approaches.

    Main Results:

    • Hirsutism has diverse causes, ranging from benign conditions to serious tumors.
    • Treatment strategies are varied, including medical, cosmetic, and surgical interventions.

    Conclusions:

    • Accurate diagnosis is crucial for effective hirsutism management.
    • A multidisciplinary approach is often necessary for optimal patient outcomes.